Patients with familial biparental hydatidiform moles have normal methylation at imprinted genes

European Journal of Human Genetics

Volumn 13, Issue 4, 2005, Pages 486-490

  El Maarri, Osman ^a   Seoud, Muhieddine ^b   Rivière, Jean Baptiste ^c   Oldenburg, Johannes ^a,d   Walter, Jörn ^e   Rouleau, Guy ^c   Slim, Rima ^f,g  

^a Inst Exp Haematol/Transfus Med   (Germany)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d Inst Transfus Med I   (Germany)

^e SAARLAND UNIVERSITY   (Germany)

^f MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^g MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Hydatidiform moles; Imprinting; Methylation analysis; Molar pregnancy; SIRPH

Indexed keywords

DNA; GENE PRODUCT; NESP55 PROTEIN; PEG3 PROTEIN; RNA H19; SNRPN PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; DNA METHYLATION; EXTRACHROMOSOMAL INHERITANCE; FAMILIAL DISEASE; FEMALE; GENE EXPRESSION; GENOME IMPRINTING; GERM LINE; HAPLOTYPE; HUMAN; HUMAN TISSUE; HYDATIDIFORM MOLE; MICROSATELLITE MARKER; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT DISEASE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; ZYGOTE;

ALLELES; AUTOANTIGENS; DNA METHYLATION; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOMIC IMPRINTING; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; HYDATIDIFORM MOLE; MALE; PEDIGREE; PREGNANCY; PROTEIN KINASES; RIBONUCLEOPROTEINS, SMALL NUCLEAR; RNA, UNTRANSLATED; TRANSCRIPTION FACTORS;

EID: 17144378271     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201353     Document Type: Article

References (22)

1. Judson H, Hayward BE, Sheridan E, Bonthron DT. A global disorder of imprinting in the human female germ line. Nature 2002; 416: 539-542.
2. Fisher RA, Hodges MD, Rees HC et al: The maternally transcribed gene p57(KIP2) (CDNK1C) is abnormally expressed in both androgenetic and biparental complete hydatidiform moles. Hum Mol Genet 2002; 11: 3267-3272.
3. El-Maarri O, Seoud M, Coullin P et al: Maternal alleles acquiring paternal methylation patterns in biparental complete hydatidiform moles. Hum Mol Genet 2003; 12: 1405-1413.
4. Nelen WL, Blom HJ, Steegers EA, den Heijer M, Eskes TK: Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis. Fertil Steril 2000; 74: 1196-1199.
5. Nelen WL, Blom HJ, Steegers EA, den Heijer M, Thomas CM, Eskes TK: Homocysteine and folate levels as risk factors for recurrent early pregnancy loss. Obstet Gynecol 2000; 95: 519-524.
6. Nelen WL, Bulten J, Steegers EA, Blom HJ, Hanselaar AG, Eskes TK: Maternal homocysteine and chorionic vascularization in recurrent early pregnancy loss. Hum Reprod 2000; 15: 954-960.
7. Barro C, Ducros V, Bonaz B et al: Homocysteinemia and recurrent fetal losses: description of three cases. Ann Biol Clin (Paris) 2002; 60: 325-326.
8. Kumar KS, Govindaiah V, Naushad SE, Devi RR, Jyothy A: Plasma homocysteine levels correlated to interactions between folate status and methylene tetrahydrofolate reductase gene mutation in women with unexplained recurrent pregnancy loss. J Obstet Gynaecol 2003; 23 55-58.
9. Reznikoff-Etievant MF, Zittoun J, Vaylet C, Pernet P, Milliez J: Low vitamin B12 level as a risk factor for very early recurrent abortion. Obstet Gynecol 2002; 104: 156-159.
10. Moglabey YB, Kircheisen R, Seoud M, El Mogharbel N, Van den Veyver I, Slim R: Genetic mapping of a maternal locus responsible for familial hydatidiform moles. Hum Mol Genet 1999; 8: 667-671.
11. El-Maarri O, Herbiniaux U, Walter J, Oldenburg J: A rapid, quantitative, non-radioactive bisulfite-SNuPE-IP RP HPLC assay for methylation analysis at specific CpG sites. Nucleic Acids Res 2002; 30: e25.
12. El-Maarri O: SIRPH analysis: SNuPE with IP-RP-HPLC for quantitative measurements of DNA methylation at specific CpG sites. Methods Mol Biol 2004; 287: 195-206.
13. Steenman MJ, Rainier S, Dobry CJ et al: Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumor. Nat Genet 1994; 7: 433-439.
14. Moulton T, Crenshaw T, Hao Y et al: Epigenetic lesions at the H19 locus in Wilms' tumour patients. Nat Genet 1994; 7 440-447.
15. Kondo M, Suzuki H, Ueda R et al: Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers. Oncogene 1995; 10: 1193-1198.
16. Taniguchi T, Sullivan MJ, Ogawa O, Reeve AE: Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor. Proc Natl Acad Sci USA 1995; 93: 2159-2163.
17. Hashimoto K, Azuma C, Tokugawa Y et al: Loss of H19 imprinting and up-regulation of H19 and SNRPN in a case with malignant mixed Mullerian tumor of the uterus. Hum Pathol 1997; 28: 862-865.
18. Li X, Kigner P, Sandstedt B et al: Promoter-specific methylation and expression alterations of Igf2 and H19 are involved in human hepatoblastoma. Int J Cancer 1998; 75: 176-180.
19. Maegawa S, Yoshioka H, Itaba N et al: Epigenetic silencing of PEG3 gene expression in human glioma cell lines. Mol Carcinogen 2001; 31: 1-9.
20. Cui H, Niemitz EL, Ravenel JD et al: Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutation of CTCF or its binding site. Cancer Res 2001; 61: 4947-4950.
21. Nakagawa H, Chadwick RB, Peltomäki P, Plass C, Nakamura Y, de la Chapelle A: Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites on colorectal cancer. Proc Natl Acad Sci USA 2001; 98: 591-596.
22. Mann MR, Lee SS, Doherty AS et al: Selective loss of imprinting in the placenta following preimplantation development in culture. Development 2004; 131: 3727-3735.